Monthly information on share capital and company voting rights
Cellectis has released its monthly share capital and voting rights report as of December 31, 2024. The company reported a total of 100,093,873 shares in the capital and 88,660,539 voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority, as the company is listed on Euronext Growth under ISIN code FR0010425595.
Cellectis ha pubblicato il suo rapporto mensile sul capitale azionario e sui diritti di voto al 31 dicembre 2024. L'azienda ha riportato un totale di 100.093.873 azioni nel capitale e 88.660.539 diritti di voto. Questa divulgazione è effettuata in conformità con l'Articolo 223-16 del Regolamento Generale dell'Autorità dei Mercati Finanziari francese, poiché l'azienda è quotata su Euronext Growth con codice ISIN FR0010425595.
Cellectis ha publicado su informe mensual sobre el capital social y los derechos de voto al 31 de diciembre de 2024. La empresa informó de un total de 100.093.873 acciones en el capital y 88.660.539 derechos de voto. Esta divulgación se realiza de acuerdo con el Artículo 223-16 del Reglamento General de la autoridad de los mercados financieros franceses, ya que la empresa está cotizada en Euronext Growth bajo el código ISIN FR0010425595.
Cellectis는 2024년 12월 31일 기준의 월간 자본금 및 의결권 보고서를 발표했습니다. 회사는 총 100,093,873 주식이 자본에 있으며 88,660,539 의결권을 보유하고 있다고 보고했습니다. 이러한 공시는 회사가 Euronext Growth에 상장되어 있으며 ISIN 코드 FR0010425595에 따라 프랑스 금융 시장 당국의 일반 규정 제223-16조에 따라 이루어집니다.
Cellectis a publié son rapport mensuel sur le capital social et les droits de vote au 31 décembre 2024. L'entreprise a déclaré un total de 100.093.873 actions dans le capital et 88.660.539 droits de vote. Cette divulgation est faite conformément à l'Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers française, car l'entreprise est cotée sur Euronext Growth sous le code ISIN FR0010425595.
Cellectis hat ihren monatlichen Bericht über das Grundkapital und die Stimmrechte zum 31. Dezember 2024 veröffentlicht. Das Unternehmen berichtete von insgesamt 100.093.873 Aktien im Kapital und 88.660.539 Stimmrechten. Diese Offenlegung erfolgt gemäß Artikel 223-16 der Allgemeinen Vorschriften der französischen Finanzmarktaufsichtsbehörde, da das Unternehmen an Euronext Growth unter der ISIN-Nummer FR0010425595 notiert ist.
- None.
- None.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Jan. 08, 2025 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 12/31/2024 | 100,093,873 | 88,660,539 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Attachment
FAQ
How many total shares does Cellectis (CLLS) have as of December 31, 2024?
What is the current number of voting rights for Cellectis (CLLS)?
On which exchange is Cellectis (CLLS) stock listed?
What is the ISIN code for Cellectis (CLLS) shares?
